Women with kidney transplants may face higher pregnancy risks when using assisted reproductive technology (ART), a new study from the University of Cincinnati reveals. Featured in Contemporary OB/GYN, the research led by nephrology associate professor Silvi Shah, MD, sheds light on a previously murky area of reproductive health. According to the findings, which are among the first to be so comprehensive, this group of women is at an increased risk of hypertension, cesarean delivery, preterm birth, and having infants with lower birth weights.
"Our study provides valuable evidence to guide physicians when counseling patients toward family-planning decision-making and the use of assisted reproductive technology," Shah told Contemporary OB/GYN via UC News. Despite the more pronounced risks, the study noted that the rates of live births and two-year kidney transplant survival did not significantly increase, which suggests that ART can still be a safe option for these patients. This is a critical distinction to make clear, as chronic kidney disease can severely dampen fertility, and transplantation often does not fully reverse this.
Many women experience improved fertility following a kidney transplant, but for those who still find themselves battling infertility, ART has become a go-to solution. The study's results, published on the University of Cincinnati's website, underline the importance of tailored advice and care for kidney transplant recipients who are to use ART to conceive.
Shah hopes that the data will serve to inform clinicians and patients alike. "this data now allows for a greater understanding of how clinicians can optimize care for kidney transplant recipients planning to conceive with ART," she explained via UC News. The information could prove instrumental for these women to make fully informed reproductive choices, weighing the newfound risks against their desire to have children through assisted means.
